-
Symbol
-
ALLO on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
COMMON STOCK
-
Latest Disclosed Ownership
-
10.9M shares
-
Security Ownership
-
5.1%
David D. Chang, M.D., Ph.D. ownership in Allogene Therapeutics, Inc. COMMON STOCK (ALLO)
2025-02-13 - David D. Chang, M.D., Ph.D. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.9M shares of Allogene Therapeutics, Inc. COMMON STOCK (ALLO).
This represents 5.1% percent ownership of the company.